Aminocaproic Acid + Anti Inhibitor Coagulant Complex Interaction

Majorinteraction on record

Description

Systemic antifibrinolytic; increased risk of thrombotic events. Use not recommended within 6-12 hours after FEIBA administration.

Mechanism

Antifibrinolytic mechanism may increase thrombotic risk with FEIBA

Source: NLP:anti-inhibitor coagulant complex